Carcinoid Tumor
📧 Sign up to get email alerts when something new happens for Carcinoid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome [Phase 2]
Phase 2 study of paltusotine in patients with carcinoid syndrome completed with results posted, detailing safety, pharmacokinetics, and dose…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Cabozantinib and Nivolumab for Carcinoid Tumors [Phase 2]
A Phase 2 study evaluating the combination of cabozantinib and nivolumab for carcinoid tumors has completed with results posted in January 2…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in patients with advanced pancreatic neuroendocrine tumors and carcinoid tumors; results have been pos…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in advanced pancreatic neuroendocrine and carcinoid tumors; ACTIVE_NOT_RECRUITING with results posted …
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
This clinical trial update reports the completion of studies examining biomarkers of angiogenesis in renal cell carcinoma and neuroendocrine…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors [Phase 2]
A Phase II study evaluated ramucirumab with a somatostatin analog in patients with advanced, progressive carcinoid tumors. The trial has com…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating nivolumab with ipilimumab in neuroendocrine tumors (including carcinoid) has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 2]
Phase 2 clinical trial update for cabozantinib in advanced pancreatic neuroendocrine tumors and carcinoid tumors has completed with results …
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors [Phase 2]
Phase 2 clinical trial update for Ziv-Aflibercept in advanced progressive carcinoid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating nintedanib in locally advanced or metastatic neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) [Phase 2]
Phase 2 trial evaluation of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy [Phase 2]
Phase 2 clinical trial update investigating peptide receptor radiotargeted therapy for carcinoid heart disease and carcinoid syndrome/tumor.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: GA-68 DOTA-TOC of Somatostatin Positive Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for GA-68 DOTA-TOC targeting somatostatin receptors in neuroendocrine tumors and related malignancies, with …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe [Phase 2]
Phase 2 RAMSETE trial evaluating RAD001 (everolimus) in advanced and metastatic silent neuroendocrine tumors; results were posted in January…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion [Phase 3]
A Phase 3 clinical trial evaluating the effect of oral 5-HTP on urinary 5-HIAA excretion was terminated.
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of AMG 479 in advanced carcinoid tumors and pancreatic neuroendocrine tumors has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: A Study of Axitinib in Advanced Carcinoid Tumors [Phase 2]
Phase 2 trial update for axitinib in advanced carcinoid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: 68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs) [Phase 1]
A Phase 1 trial evaluating the PET imaging agent 68Ga-DOTATOC for somatostatin receptor–positive neuroendocrine tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: EPO906 in Carcinoid and Other Neuroendocrine Tumors [Phase 2]
Phase 2 trial of EPO906 (irofulven) in carcinoid tumors and other neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors [Phase 1]
A Phase 1 trial assessing the combination of pasireotide and RAD001 (everolimus) in patients with advanced neuroendocrine tumors has complet…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid [Phase 2]
A Phase 2 trial of RAD001 (everolimus) for pheochromocytoma, extra-adrenal paraganglioma, and non-functioning carcinoid has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors [Phase 1]
Phase 1 trial update of sorafenib in combination with RAD001 (everolimus) in patients with advanced neuroendocrine tumors, including carcino…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68Ga-DOTATATE PET imaging in patients with neuroendocrine tumors to assess diagnostic performance.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease [Phase 3]
Phase 3 trial comparing pasireotide long-acting release to octreotide long-acting release in patients with metastatic carcinoid disease; the…
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor [Phase 3]
A Phase 3 trial evaluating the combination of everolimus and octreotide in patients with advanced carcinoid tumor has completed and posted r…